Ownership Summary
Harvard Bioscience Inc (NASDAQ:HBIO) has 64 institutional investors that have filed 13F reports for the period ending December 2025.
- These investors held 39.5% of outstanding shares in December 2025, up from 38.4% in September 2025.
- They increased total shares held in Harvard Bioscience by 87.82% from the prior quarter, while the number of investors in HBIO decreased 34.02% year over year.
- Among the 64 funds, 33 bought more Harvard Bioscience shares, 19 sold down, and 12 held their ground.
- Combined, these investors held 17.62Mn shares in HBIO for December 2025, up by 8.24Mn shares quarter on quarter, and down 13.84Mn shares year over year.
- Meros Investment Management, LP is the top holder of Harvard Bioscience as of December 31, 2025, with 118.52K shares representing 0.27% of outstanding stock.
- The largest buyers of Harvard Bioscience for the quarter ending December 2025 were NANO CAP NEW MILLENNIUM GROWTH FUND L P (57.5K).
- The largest sellers of Harvard Bioscience for the quarter ending December 2025 were Meros Investment Management, LP (3.24K).
- Harvard Bioscience's 3 largest shareholders as of December 2025 include Meros Investment Management, LP (118.52K), NANO CAP NEW MILLENNIUM GROWTH FUND L P (117.5K), Financial Connections Group, Inc. (30) per Business Quant data.